Feature | Cybersecurity | May 16, 2018

Heart Rhythm Society Recommends How to Prepare for Cybersecurity Threats to Cardiac Implantable Devices

HRS statement aimed at countering threats to implantable pacemakers and ICDs

Heart Rhythm Society (HRS) Offers Recommendations to Prepare for Cybersecurity Threats to Cardiac Implantable Devices in new consensus document. #HRS2018

May 16, 2018 — The Heart Rhythm Society (HRS) released communication recommendations to assist healthcare professionals to understand and prepare for potential cybersecurity vulnerabilities of cardiovascular implantable electronic devices (CIEDs). The statement was released during Heart Rhythm 2018 conference last week. 

The statement outlines four key communication themes: 
   1. When to notify patients;
   2. Whom to notify;
   3. How to communicate with patients; and 
   4. What elements to discuss with patients.  

The relative novelty of cybersecurity threats in CIEDs is raising questions among patients and the heart rhythm care community. The rapidly changing healthcare environment and increasing global interconnectivity expose information technology to new vulnerabilities. Hackers can potentially use these vulnerabilities to gain unauthorized access to medical equipment. 

The proceedings statement includes detailed guidance on patient-centered communication strategies when a specific threat is identified. The authors first call for an assessment of the threat by experts from manufacturers and U.S. federal agencies. If a vulnerability is validated, the discussion between the healthcare professional and patient should include five topics: 
   1. Potential consequences if the vulnerability is exploited;
   2.Strategies to mitigate the risks;
   3. Technical challenges to exploit the vulnerability;
   4. Long-term solutions to eliminate the threat; and
   5. Benefits provided by the CIED compared with the risk if the vulnerability is exploited.
 
The authors note that if the claim of a new vulnerability is released directly to the public, instead of directly to the manufacturer or the U.S. Food and Drug Administration (FDA), there is the potential for a period of uncertainty and anxiety during the evaluation of the claim. U.S. federal agencies and manufacturers must rapidly assess both the validity of the claim and the potential risks to patients to prevent improper action or exploitation of the situation.  

"As we look ahead and plan for ways to deal with potential risks to CIEDs, preparedness is the best approach," said lead author David Slotwiner, M.D., FHRS, New York-Presbyterian Queens. "Like other technology such as smartphones or computers, device software needs to be regularly updated. As healthcare professionals, we are inclined to first address hardware issues with the battery or leads, but the software is equally important. The healthcare community must reach a point where routine software updates are considered the standard of care to minimize the threat and ultimately eliminate risks." 

The authors also state the importance of managing patient expectations at the time of implant. Patients should know that CIEDs will require software updates until the battery is depleted. By educating patients prior to CIED implant and in advance of a threat announcement, patients will have a better understanding of the systems and be more prepared to respond to a potential vulnerability. HRS will work with its partners to help educate health care professionals on best practices for patient-centered conversations and mechanisms to minimize cybersecurity risks.

The statement captures the proceedings of the 2017 Leadership Summit on Cybersecurity Vulnerabilities: Communications Strategies for Clinicians and Patients that was attended by patient representatives, subject matter experts, HRS and American College of Cardiology (ACC) leadership, FDA and Federal Bureau of Investigation (FBI) officials, and leadership from CIED manufacturers. 

The full document was published with an accompanying editorial commentary in the online edition of HeartRhythm, the official journal of HRS. Review the full document and editorial commentary by FDA.

Find links to all the Heart Rhythm 2018 Late-breaking Studies

 

Related Cardiovascular Device Cybersecurity Content:

Can Your Cardiac Device Be Hacked?

Raising the Bar for Medical Device Cyber Security

The State of Healthcare Cyber Security

FDA Seeks Management of Cybersecurity in Medical Devices

Cybersecurity Threats in Medical Imaging

FDA Announces New Medical Device Safety Action Plan

 

Reference:

1. David J. Slotwiner, David J. Slotwiner, David J. Slotwiner, et al.  Cybersecurity Vulnerabilities of Cardiac Implantable Electronic Devices: Communication Strategies for Clinicians—Proceedings of the Heart Rhythm Society's Leadership Summit. HeartRhythm. DOI: https://doi.org/10.1016/j.hrthm.2018.05.001
 

#HRS2018  #HRS18

 

 

Related Content

Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.

Image from the announcement of the Neal award winner of best technical content for DAIC's coverage of COVID-10 related to cardiology at the Neal virtual award ceremony June 9.

Feature | Cardiovascular Business | June 10, 2021
Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

Avoiding high-risk PCI procedures does not improve hospital scores according to a study presented at SCAI 2021. CTO procedure at Henry Ford Hospital, Detroit. Photo by Dave Fornell.

News | Cardiovascular Business | May 05, 2021
May 5, 2021 — A late-breaking study presented at the...
Cardinal Health Sells its Cordis Cardiology Business to Hellman & Friedman. Hopes to build the Cordis Accelerator for innovative cardiovascular device development.
News | Cardiovascular Business | March 12, 2021
March 12, 2021 — Cardinal Health today announced that it is selling its...
An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

An interventional radiologist consults with a patient in an out patient cath lab at a Modern Vascular clinic. The company is building several out patient clinics to capture a share of the interventional market for peripheral artery disease (PAD) catheter-based therapies. 

News | Cardiovascular Business | February 03, 2021
February 3, 2021 — Modern Vascular is a medical group that has 13 outpatient cath lab clinics to treat...
COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States. #DAIC

COVID-19 cardiology related content continues to be among the top performers on the DAIC website in November 2020. TAVR also topped headlines with Boston Scientific taking its Lotus valve off the market and a review of TAVR registry data showing it is now the dominant method of aortic valve replacement in the United States.

Feature | Cardiovascular Business | December 01, 2020 | Dave Fornell, Editor
December 1, 2020 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC
Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

Survey data showing opinions of physicians and hospital administrators on barriers to implementing new technology and how new technologies have improved cardiovascular care.

News | Cardiovascular Business | September 14, 2020
September 14, 2020 — New global research released by Abbott takes a deep dive into the barriers of cardiovascular pat
Philips angiography system in a cath lab at Henry Ford Hospital.
Feature | Cardiovascular Business | July 13, 2020 | Deb Thompson and Christian Comeau
For a cardiovascular service line leader, addressing challenges in an evolving healthcare climate is a constant.
Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

Leeds Hospital recently installed Philips Azurion angiography interventional labs to enhance procedural guidance capabilities.

News | Cardiovascular Business | July 08, 2020
July 8, 2020 – Philips Healthcare and Leeds Teaching Hospitals NHS Trust announced a seven-year managed service agree